Cassava Sciences Inc (SAVA)

$ATYR rip to people who invested here. $SAVA is a good reference point for those who think the price will recover.

$SAVA anybody see the news with $RAPP today? Interesting that SAVA is fraudulent but RAPP is still around

My only strategy since 2019 has been to buy when H% is low. Nothing else. Keep it simple and consistent. The results prove again and again why I‘ll only stick with this strategy Will trade $SAVA like how I did for others

$SAVA since the science is based on fabricated data by wang and Remi's wife, this company should just use all their cash to buy crypto $SOL.X or $ETH.X and return shareholder value. Wasting in fruitless trials so the board can get paid is robbery in broad daylight. Mark these words.

$ATYR $SAVA

$ATYR $SAVA Sava 2 Electric Boogaloo You baggies should have listened to experts outside of your echo chamber.

#mySAVAanalysis $SAVA #tuesdayZ

$GRI Who remembers $SAVA and $ANVS Alzheimers data plays when they both went above $90.00 a share on data release??? Gri bio has iPf data soon- could be that billion $ market cap mover 2.5 million share float 4.5 million market cap Trades at $1.91 1billion market cap=

$ATYR even $SAVA didnt fall this flat ...and they had no revenue stream

$SAVA 10, 000 shares now after averaging down significantly…let’s go!!

$ATYR they have any other products in the pipeline or are they pretty much $SAVA?

$ATYR had 1000 shares bought another 1000 at 1.11. Lets see if this gets back to $2.5 like $SAVA . They're in a better situation than SAVA

$ATYR $SAVA sorry bulls just money

$ATYR knocked-> Martin strike again after $SAVA

$ATYR will buy some here. Probably recover to $2 range like $SAVA

$SAVA $5

$SAVA is a reminder not to invest in independent biotech trying to disrupt billion dollar business models. Almost a year since the nonsensical, never-seen-before placebo effect ruined the results and the lives of many. They couldn't void the patents and steal them. Couldn't stop the trials. They have locked down people and made violent personal attacks to tarnish reputations. So they did what they had to do to make it match they narrative. Almost a year now. I remember it as if it was yesterday. Ironically, we've seen many posts from more experienced investors warning is and who knew exactly it would happen again as it always happens when an independent biotech makes some breakthrough in medical research. I particularly remember a striking post reminding the story of researchers who got mysteriously killed after breakthrough results for a drug. Human nature can be terrifying.

$ANVS Post 2 of … @cheesedonkey: Andy, I think that honest and reflective investors owe @CC_Abbott more a just an apology. I think we should support her published works. It is a common tendency for investors to loose objectivity once they make an investment. CC_Abbott’s work, along with others shouldn’t be threatening to investors. It should provide balance. This includes an investor’s ability to re-evaluate their investment decision, weighting it for better performance and more importantly, for capital preservation. Dr. Maria Maccecchini is lying when she states she has “no clue why” CC hates her guts. Dr. Maccecchini is threatened by the truth. She has taken external and internal initiatives. This is not conjecture on my part as Dr. Maccecchini outlined this via email to me along with another Annovis Bio executive. The National Institute on Aging (NIA) is currently supporting 495 active clinical trials on Alzheimer’s disease and related dementias (AD/ADRD) ¹. Yet, Dr. Maccecchini promotes her herself as the one true holder of a magic drug for Alzheimer’s patients above ALL others with her statement, “At this point our drug looks more promising than any Alzheimer drug on the market or in development” ². Dr. Maccecchini’s repeatedly states is that her drug, her trial study designs, her leadership, (her BoD, her SAB?), … are better than $AVXL and $CGTX and $BIVI and, of course $SAVA. IMO, her drug trials are "designed" to be grey intentionally so that she can perpetuate this cause for her own benefit. Curiously, to me are Annovis Bio investors who attack Cassava Sciences as a scam. Yes, the SEC penalized SAVA $40M along with two former executives — founder Remi Barbier ($175,000 fine) and former SVP Lindsay Burns ($85,000 fine) ³. However, ANVS is NOT what investors assume it is. ANVS is potentially as harmful to investors and patients as SAVA, if not more so. Andy, your Stocktwits account currently displays “2310 Results” for “$ANVS from @chessedonkey”. This count does not include replies. I would encourage you and others to do more with the information that I have been providing over the last 24 hours than “just go back to doing [my] own thing until Maria can actually keep a promise”. She make promises she NEVER intends to fulfill. Please actively participate on this channel again and hold Dr. Maccecchini to her word. Additionally, I know that you had a falling out with @papatrick who was also heavily invested in Annovis Bio previously and suffered substantial loses. You didn’t like the negative tone of papa’s comments, but he knows a lot about this company. Maria is very likely a crook (which is based on contemporaneous notes I have taken on a telephone calls she made to me, along with the many other interactions via email, video conference, and other communication platform that I have interacted with her and her associates on.) But, why should investors believe me? Aren’t they better off believing in the CEO who has fired all of her CFOs instead??? I think the evidence is heavy even given how little I am able to disclose. A majority of the current ANVS investors have chosen to discredit me instead of protecting prospective investors from being lured in by Dr. Maccecchini’s false claims of drug efficacy for their loved ones. I hope that you, Andy, aren’t among that cluster of “investors” who have chosen to take that path. Sincerely, Tessa Footnotes: ¹ https://www.nia.nih.gov/research/ongoing-AD-trials ² https://stocktwits.com/MaccM/message/606412928 ³ https://www.sec.gov/newsroom/press-releases/2024-151#:~:text=Without%20admitting%20or%20denying%20the%20allegations%2C%20Cassava%2C,of%20$40%20million%2C%20$175%2C000%2C%20and%20$85%2C000%2C%20respectively. #CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #NIH #NIA #SEC

Enter: $SAVA OCT 03 2025 $2 CALLS Buy in Price: $0.08 - $0.10 Take Profit: $0.09 Stop Bleeding: $0.07 ROI Potential: 15% Exit Within: 52 Minutes https://moneygroup.us/alerts

$ATYR This is gonna end up same way like $SAVA

Looks like ALL volume and momentum are shifting in to CMCT! Shorts overextended and now bulls can have them trapped at the bottom. CMCT Could pull a huge multi day run - only 700k float! Don't miss CMCT..,it's breaking out! $RR $SAVA $GEVO $OCGN 2021